Literature DB >> 17875967

Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction.

Vincent F M Segers1, Tomotake Tokunou, Luke J Higgins, Catherine MacGillivray, Joseph Gannon, Richard T Lee.   

Abstract

BACKGROUND: Local delivery of chemotactic factors represents a novel approach to tissue regeneration. However, successful chemokine protein delivery is challenged by barriers including the rapid diffusion of chemokines and cleavage of chemokines by proteases that are activated in injured tissues. Stromal cell-derived factor-1 (SDF-1) is a well-characterized chemokine for attracting stem cells and thus a strong candidate for promoting regeneration. However, SDF-1 is cleaved by exopeptidases and matrix metalloproteinase-2, generating a neurotoxin implicated in some forms of dementia. METHODS AND
RESULTS: We designed a new chemokine called S-SDF-1(S4V) that is resistant to matrix metalloproteinase-2 and exopeptidase cleavage but retains chemotactic bioactivity, reducing the neurotoxic potential of native SDF-1. To deliver S-SDF-1(S4V), we expressed and purified fusion proteins to tether the chemokine to self-assembling peptides, which form nanofibers and allow local delivery. Intramyocardial delivery of S-SDF-1(S4V) after myocardial infarction recruited CXCR4+/c-Kit+ stem cells (46+/-7 to 119+/-18 cells per section) and increased capillary density (from 169+/-42 to 283+/-27 per 1 mm2). Furthermore, in a randomized, blinded study of 176 rats with myocardial infarction, nanofiber delivery of the protease-resistant S-SDF-1(S4V) improved cardiac function (ejection fraction increased from 34.0+/-2.5% to 50.7+/-3.1%), whereas native SDF-1 had no beneficial effects.
CONCLUSIONS: The combined advances of a new, protease-resistant SDF-1 and nanofiber-mediated delivery promoted recruitment of stem cells and improved cardiac function after myocardial infarction. These data demonstrate that driving chemotaxis of stem cells by local chemokine delivery is a promising new strategy for tissue regeneration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17875967     DOI: 10.1161/CIRCULATIONAHA.107.718718

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  120 in total

Review 1.  Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step.

Authors:  James D Richardson; Adam J Nelson; Andrew C W Zannettino; Stan Gronthos; Stephen G Worthley; Peter J Psaltis
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

2.  Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1alpha delivery and endogenous cytokine signaling.

Authors:  Tiemin Zhao; Dongsheng Zhang; Ronald W Millard; Muhammad Ashraf; Yigang Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-30       Impact factor: 4.733

Review 3.  Functional diversity of SDF-1 splicing variants.

Authors:  Miroslaw Janowski
Journal:  Cell Adh Migr       Date:  2009-07-23       Impact factor: 3.405

4.  Homing of stem cells to ischemic myocardium.

Authors:  Sharven Taghavi; Jon C George
Journal:  Am J Transl Res       Date:  2013-05-24       Impact factor: 4.060

Review 5.  Genetic enhancement of stem cell engraftment, survival, and efficacy.

Authors:  Marc S Penn; Abeel A Mangi
Journal:  Circ Res       Date:  2008-06-20       Impact factor: 17.367

Review 6.  Murine xenogeneic models of myelodysplastic syndrome: an essential role for stroma cells.

Authors:  Xiang Li; H Joachim Deeg
Journal:  Exp Hematol       Date:  2013-10-11       Impact factor: 3.084

7.  Growth factor delivery through self-assembling peptide scaffolds.

Authors:  Rachel E Miller; Paul W Kopesky; Alan J Grodzinsky
Journal:  Clin Orthop Relat Res       Date:  2011-10       Impact factor: 4.176

Review 8.  Hematopoietic stem cell homing to injured tissues.

Authors:  Dean Philip John Kavanagh; Neena Kalia
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

Review 9.  Cell therapy for the treatment of coronary heart disease: a critical appraisal.

Authors:  Kai C Wollert; Helmut Drexler
Journal:  Nat Rev Cardiol       Date:  2010-02-23       Impact factor: 32.419

Review 10.  Re-engineered stromal cell-derived factor-1α and the future of translatable angiogenic polypeptide design.

Authors:  William Hiesinger; Andrew B Goldstone; Y Joseph Woo
Journal:  Trends Cardiovasc Med       Date:  2012-08-16       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.